Search results
Bristol Myers wins dismissal of a $6.4 billion lawsuit over cancer drug delay
Reuters via Yahoo Canada News· 1 year agoNEW YORK (Reuters) -A U.S. judge on Wednesday dismissed a lawsuit accusing Bristol Myers Squibb Co...
Bristol Myers wins dismissal of lawsuit over Celgene drugs
Reuters via Yahoo Finance Canada· 1 year agoNEW YORK, March 1 (Reuters) - A U.S. judge on Wednesday dismissed a lawsuit accusing Bristol Myers Squibb Co of defrauding investors who stood to receive $6.4 billion had it won federal approval ...
Intellia (NTLA) Shares Fall as CFO Glenn Goddard Steps Down
Zacks via Yahoo Finance Canada· 1 week agoShares of Intellia Therapeutics, Inc. NTLA were down 4.5% on Jun 26 after it announced that its...
Should Investors Buy Bristol Myers Squibb Stock?
Zacks via Yahoo Finance Canada· 2 years agoBMY's YTD performance indicates the stock has been a viable hedge against inflation because people can ill afford to cut back on health-focused spending.
Will New Drugs Help Bristol Myers (BMY) Combat Generic Pressure?
Zacks via Yahoo Finance Canada· 2 years agoBiotech bigwig Bristol Myers BMY has had a decent run this year despite one of its top drugs...
Bristol Myers (BMY) Gets Approval of Psoriasis Drug in EU
Zacks via Yahoo Finance Canada· 1 year agoBristol Myers' (BMY) Sotyktu gets approval from the European Commission to treat adults with...
GSK's blood cancer drug fails main goal of trial, shares fall
Reuters via Yahoo Canada News· 2 years ago(Reuters) -GSK's blood cancer drug Blenrep failed the main goal of a late-stage study designed to...
Bristol Myers CEO Caforio to step down
Reuters via Yahoo Finance Canada· 1 year agoBoerner, who has been CCO since 2018, was named chief operating officer until he takes the top job. Boerner said he is aligned with Caforio on the...
New U.S. cancer drug prices rise 53% in five years -report
Reuters via Yahoo Canada News· 2 years agoThe annual price of a newly-launched cancer drug in the United States averaged $283,000 last year, a...
54gene CEO steps down as the company looks to cut more jobs
TechCrunch via Yahoo Canada News· 2 years ago54gene co-founder and chief executive officer Dr. Abasi Ene-Obong has stepped down from his...
